Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

To address the rising bird flu cases, the US government has committed $590 million to fast-track Moderna's mRNA bird flu ...

The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, ...

Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...

The version of the virus spreading in North America right now has led to only a few serious cases, but concerns have been ...

The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu ...

Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could ...